Insider Trading History of Wilson Martin

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Wilson Martin since 2018. This trader's CIK number is 1704342. At the time of last reporting, Wilson Martin was the General Counsel of Rocket Pharmaceuticals, Inc.. (stock ticker symbol RCKT). Also see all insider trading activities at Rocket Pharmaceuticals, Inc..

Note that in the past Wilson Martin also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Rocket Pharmaceuticals, Inc. (RCKT) by Wilson Martin

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 RCKT 0 $0 17,510 $79,266 0 $0
2024 RCKT 0 $0 8,703 $245,960 9,712 $0

Yearly summary of insider trading at Teligent, Inc. (TLGT) by Wilson Martin

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 TLGT 0 $0 0 $0 5,000 $0


Insider trading activities at 2 companies by Wilson Martin:

1. Rocket Pharmaceuticals, Inc. (RCKT)

2. Teligent, Inc. (TLGT)

Table 1. Insider trading of Rocket Pharmaceuticals, Inc. (RCKT) by Wilson Martin

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-08-18 RCKT Sale 1,004 3.06 3,077
2025-08-19 RCKT Sale 588 3.00 1,761
2025-08-14 RCKT Sale 12,109 3.02 36,557
2025-05-20 RCKT Sale 587 6.45 3,783
2025-02-21 RCKT Sale 3,222 10.58 34,088
2024-08-16 RCKT Sale 1,027 18.50 19,003
2024-02-29 RCKT Sale 4,100 29.33 120,257
2024-02-16 RCKT Sale 3,576 29.84 106,700
2024-02-14 RCKT Option Ex 9,712 .00 0

Table 2. Insider trading of Teligent, Inc. (TLGT) by Wilson Martin

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-04-25 TLGT Option Ex 5,000 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wilson Martin (General Counsel of Rocket Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.